500 related articles for article (PubMed ID: 26889029)
21. Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines.
Hayashi H; Kubo Y; Izumida M; Takahashi E; Kido H; Sato K; Yamaya M; Nishimura H; Nakayama K; Matsuyama T
Front Cell Infect Microbiol; 2018; 8():91. PubMed ID: 29629340
[TBL] [Abstract][Full Text] [Related]
22. SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
Straus MR; Kinder JT; Segall M; Dutch RE; Whittaker GR
Virology; 2020 Apr; 543():43-53. PubMed ID: 32056846
[TBL] [Abstract][Full Text] [Related]
23. TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1.
Zmora P; Hoffmann M; Kollmus H; Moldenhauer AS; Danov O; Braun A; Winkler M; Schughart K; Pöhlmann S
J Biol Chem; 2018 Sep; 293(36):13863-13873. PubMed ID: 29976755
[TBL] [Abstract][Full Text] [Related]
24. Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice.
Lambertz RLO; Pippel J; Gerhauser I; Kollmus H; Anhlan D; Hrincius ER; Krausze J; Kühn N; Schughart K
J Gen Virol; 2018 Sep; 99(9):1187-1198. PubMed ID: 30084768
[TBL] [Abstract][Full Text] [Related]
25. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Shimotai Y; Hatachi Y; Lusamba Kalonji N; Tando Y; Kitajima Y; Matsuo K; Kubo H; Nagatomi R; Hongo S; Homma M; Nishimura H
Pulm Pharmacol Ther; 2015 Aug; 33():66-74. PubMed ID: 26166259
[TBL] [Abstract][Full Text] [Related]
26. Hemagglutinin Stability Regulates H1N1 Influenza Virus Replication and Pathogenicity in Mice by Modulating Type I Interferon Responses in Dendritic Cells.
Russier M; Yang G; Briard B; Meliopoulos V; Cherry S; Kanneganti TD; Schultz-Cherry S; Vogel P; Russell CJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694942
[TBL] [Abstract][Full Text] [Related]
27. Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis.
Lambertz RLO; Gerhauser I; Nehlmeier I; Leist SR; Kollmus H; Pöhlmann S; Schughart K
J Gen Virol; 2019 Jul; 100(7):1073-1078. PubMed ID: 31099738
[TBL] [Abstract][Full Text] [Related]
28. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
Böttcher E; Matrosovich T; Beyerle M; Klenk HD; Garten W; Matrosovich M
J Virol; 2006 Oct; 80(19):9896-8. PubMed ID: 16973594
[TBL] [Abstract][Full Text] [Related]
29. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.
Beaulieu A; Gravel É; Cloutier A; Marois I; Colombo É; Désilets A; Verreault C; Leduc R; Marsault É; Richter MV
J Virol; 2013 Apr; 87(8):4237-51. PubMed ID: 23365447
[TBL] [Abstract][Full Text] [Related]
30. Activation of influenza A viruses by host proteases from swine airway epithelium.
Peitsch C; Klenk HD; Garten W; Böttcher-Friebertshäuser E
J Virol; 2014 Jan; 88(1):282-91. PubMed ID: 24155384
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of influenza virus infection and hemagglutinin cleavage by the protease inhibitor HAI-2.
Hamilton BS; Chung C; Cyphers SY; Rinaldi VD; Marcano VC; Whittaker GR
Biochem Biophys Res Commun; 2014 Jul; 450(2):1070-5. PubMed ID: 24978308
[TBL] [Abstract][Full Text] [Related]
32. Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.
Baron J; Tarnow C; Mayoli-Nüssle D; Schilling E; Meyer D; Hammami M; Schwalm F; Steinmetzer T; Guan Y; Garten W; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2013 Feb; 87(3):1811-20. PubMed ID: 23192872
[TBL] [Abstract][Full Text] [Related]
33. TMPRSS2 Independency for Haemagglutinin Cleavage In Vivo Differentiates Influenza B Virus from Influenza A Virus.
Sakai K; Ami Y; Nakajima N; Nakajima K; Kitazawa M; Anraku M; Takayama I; Sangsriratanakul N; Komura M; Sato Y; Asanuma H; Takashita E; Komase K; Takehara K; Tashiro M; Hasegawa H; Odagiri T; Takeda M
Sci Rep; 2016 Jul; 6():29430. PubMed ID: 27389476
[TBL] [Abstract][Full Text] [Related]
34. Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
Böttcher-Friebertshäuser E; Lu Y; Meyer D; Sielaff F; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2012 Dec; 30(51):7374-80. PubMed ID: 23072892
[TBL] [Abstract][Full Text] [Related]
35. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
[TBL] [Abstract][Full Text] [Related]
36. Pathogenicity and transmissibility of novel reassortant H3N2 influenza viruses with 2009 pandemic H1N1 genes in pigs.
Ma J; Shen H; Liu Q; Bawa B; Qi W; Duff M; Lang Y; Lee J; Yu H; Bai J; Tong G; Hesse RA; Richt JA; Ma W
J Virol; 2015 Mar; 89(5):2831-41. PubMed ID: 25540372
[TBL] [Abstract][Full Text] [Related]
37. Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.
Meyer D; Sielaff F; Hammami M; Böttcher-Friebertshäuser E; Garten W; Steinmetzer T
Biochem J; 2013 Jun; 452(2):331-43. PubMed ID: 23527573
[TBL] [Abstract][Full Text] [Related]
38. DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.
Zmora P; Blazejewska P; Moldenhauer AS; Welsch K; Nehlmeier I; Wu Q; Schneider H; Pöhlmann S; Bertram S
J Virol; 2014 Oct; 88(20):12087-97. PubMed ID: 25122802
[TBL] [Abstract][Full Text] [Related]
39. Novel insights into proteolytic cleavage of influenza virus hemagglutinin.
Bertram S; Glowacka I; Steffen I; Kühl A; Pöhlmann S
Rev Med Virol; 2010 Sep; 20(5):298-310. PubMed ID: 20629046
[TBL] [Abstract][Full Text] [Related]
40. Protection from Severe Influenza Virus Infections in Mice Carrying the Mx1 Influenza Virus Resistance Gene Strongly Depends on Genetic Background.
Shin DL; Hatesuer B; Bergmann S; Nedelko T; Schughart K
J Virol; 2015 Oct; 89(19):9998-10009. PubMed ID: 26202236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
